PostHole
Compose
Login
The Innovation System Behind Moderna’s Covid-19 Vaccine
Noubar Afeyan, cofounder and chair of Moderna Therapeutics and CEO of Flagship Pioneering, says that the breakthrough innovation behind the company’s Covid-19 vaccine came not as a stroke of luck, but from a repeatable process. He outlines a system called “emergent discovery” that involves working back from future ideals, pioneering in novel spaces, encouraging unreasonable ideas, and persistently questioning hypotheses. And he says this process applies to other industries besides life sciences. Afeyan is the coauthor, with HBS professor Gary Pisano, of the HBR article "What Evolution Can Teach Us About Innovation."
Share Podcast
[HBR IdeaCast podcast series]
HBR IdeaCast
Episode 820
The Innovation System Behind Moderna’s Covid-19 Vaccine
Listen | Podcast loading...
###
A conversation with company cofounder Noubar Afeyan about its repeatable process for breakthrough products.
- Subscribe:
All episodes
Details
Transcript
September 23, 2021
Noubar Afeyan, cofounder and chair of Moderna Therapeutics and CEO of Flagship Pioneering, says that the breakthrough innovation behind the company’s Covid-19 vaccine came not as a stroke of luck, but from a repeatable process. He outlines a system called “emergent discovery” that involves working back from future ideals, pioneering in novel spaces, encouraging unreasonable ideas, and persistently questioning hypotheses. And he says this process applies to other industries besides life sciences. Afeyan is the coauthor, with HBS professor Gary Pisano, of the HBR article “What Evolution Can Teach Us About Innovation.”
- Subscribe On:
Latest in this series
All episodes
This article is about INNOVATION
** Follow this topic
** Following
Related Topics:
- Entrepreneurial management
- Global health